The market size value for Penicillins and Streptomycins in bulk in China has shown consistent growth from 2013 to 2023, with 2023 standing at $88.859 million. The market experienced significant growth in the early years, peaking notably in 2014 and 2015. However, growth slowed down and even saw a slight decline in 2022 before recovering with a 2.95% increase in 2023. The Compound Annual Growth Rate (CAGR) over the last five years (2018-2023) was approximately 3.01%, indicating moderate growth.
Key variations over the last two years show a decrease of 6.27% in 2022 followed by a rebound in 2023. Looking forward, the market is forecasted to grow steadily, with a 5-year CAGR of 1.96% indicating broader market stability and a total forecasted growth rate of 10.2% by 2028.
Future trends to watch for include advancements in antibiotic manufacturing technologies, shifts in global supply chain dynamics, and regulatory changes affecting pharmaceutical production and distribution in China. Additionally, emerging antibiotic resistance and the development of new antibiotic classes may also impact market dynamics.
